Several peptide-based drugs, such as dulaglutide [22], albiglutide [23], liraglutide (Victoza) [24], and glucagon-like peptide-1 (GLP-1) [25], have been approved for clinical use in treating metabolic disorders. Here, GCG is linked to metabolic disease.